Lung Cancer
A Phase 2 Study Evaluating the Efficacy, Safety, Tolerability, and Pharmacokinetics of AMG 193 in Subjects with MethylthioadenosinePhosphorylase (MTAP)-deleted Previously Treated Advanced Non- Small Cell Lung Cancer (NSCLC) (20230153)
- Details
ClinicalTrials.gov ID:
NCT06593522
Diagnosis Type:
NA
USOR Number:
- Address
,
P: